72 Nobel Laureates call for €200 billion EU research budget#
FOR SCIENCE IN EUROPE (ISE)
PRESS RELEASE – FOR IMMEDIATE RELEASE
Brussels, 13 November 2026#
Nobel laureates call on European leaders to safeguard the future of European research#
72 Nobel laureates (as of 13 November 2026) have already joined forces in an open letter to EU Heads of State and Government, urging them to allocate a budget of at least €200 billion (in current prices) for the EU’s next Framework Programme for Research and Innovation (FP10).
At a critical moment in the negotiations on the EU's long-term budget for 2028–2034, Nobel laureates from across Europe and beyond have come together to express their concern about the proposed cuts to the EU's future research budget.
In their joint letter, the laureates underline that Europe's scientific excellence, the competitiveness of its industry and its technological future depend on sustained investment in research. They call on European leaders to maintain an ambitious and independent research programme, supporting the entire spectrum from fundamental science and research careers to collaborative research and innovation.
The European Commission originally proposed €175 billion for FP10. The revised negotiating proposal presented by the Irish Presidency of the Council on 10 October 2026 would reduce this amount to approximately €158 billion. The Nobel laureates call for at least €200 billion in current prices for Horizon Europe (FP10) from 2028 to 2034, explicitly referring to Mario Draghi's call to double the EU's research framework programme budget.
Professor Ben Feringa MAE, 2016 Nobel laureate in Chemistry, states: “Science is about exploring the unknown and turning the seemingly impossible into reality. Europe’s extraordinary scientific talent helps advance our industrial strength.” Professor Peter Hegemann, 2026 Nobel laureate in Physiology or Medicine, adds: “… and long-term ERC grants power innovation. To shape our future, leaders must raise their ambitions now and invest seriously in top-level science through Horizon Europe.”
The open letter, currently signed by 72 Nobel laureates, is addressed to the EU Heads of State and Government and is being shared with national governments and relevant European institutions.
The campaign is coordinated by the Initiative for Science in Europe (ISE).
The complete letter and the names of all current signatories are reproduced below.
An appeal from Nobel Laureates: Europe must invest in the science that will shape its future#
To: the members of the European Council#
Dear Presidents, Dear Heads of State and Government,#
Europe stands at a defining moment. The decisions you take on the next Multiannual
Financial Framework will shape not only the Union’s priorities for the coming years, but
also its capacity to generate knowledge, develop transformative technologies and
secure its place in the world for decades to come.
We write to you as Nobel Laureates, united by the conviction that scientific discovery is
one of humanity’s greatest endeavours and one of Europe’s most valuable strategic
assets. We recognise the difficult circumstances in which you must make these
decisions, but we are deeply concerned with the direction in which the negotiations are
heading.
Europe cannot safeguard its future by underinvesting in the knowledge, talent and
innovation on which that future depends. European leaders have rightly identified
innovation, technological competitiveness and strategic autonomy as priorities, with
Mario Draghi calling to double the research framework programme to €200 billion.
Horizon Europe can contribute to strengthening industry and supply chains, helping
Europe meet future challenges and driving breakthroughs in key technologies, such as
artificial intelligence, quantum technologies, biotechnology, clean energy and
advanced materials.
Fundamental research is particularly important in this regard. If we fund only what
promises immediate returns, we risk losing the very breakthroughs that create entirely
new fields, industries and possibilities.
Europe is also operating in an increasingly competitive global environment. The United
States and China are investing heavily in research and technological development.
Europe’s research performance and industrial future cannot be secured through
ambition alone. They require sustained commitment and investment on a scale
commensurate with the challenge.
The EU budget should concentrate especially on things that individual Member States
cannot do efficiently alone. European-scale Research and Innovation, incl. crossborder
infrastructure and critical technologies incl. defence capabilities are obvious
examples of European public goods. EU funding brings researchers and resources
together across borders, while European competition raises standards and supports
outstanding ideas wherever they emerge. There is also a clear reason to invest together
because knowledge generated in one country can benefit people and businesses
across Europe. Security and competitiveness should therefore not be seen as
competing with solidarity. A richer, safer and technologically capable Europe is better
able to sustain solidarity over time.
For these reasons, we urge you to ensure that the next Multiannual Financial Framework
provides at least €200 billion in current prices for Horizon Europe over 2028–2034. This
should be accompanied by robust support for the next generation of researchers
through Marie Skłodowska-Curie Actions, a stronger European Research Council, and
adequate funding for collaborative basic and applied research and innovation across
the full spectrum of scientific disciplines.
Europe cannot afford to switch off the source of its future discoveries. The
decisions made now will determine whether Europe helps shape the next generation of
scientific and technological advances—or becomes increasingly dependent on others
for them.
We urge you to choose ambition, invest in knowledge and give Europe’s researchers the
means to deliver a better future for all its citizens.
Yours sincerely,
The undersigned Nobel Laureates
Signatories
As of 13 November 2026
| Nobel Laureate | Nobel Prize |
|---|---|
| Peter Hegemann | Physiology or Medicine, 2026 |
| Joachim Frank | Chemistry, 2017 |
| Gerardus't Hooft | Physics, 1999 |
| John Walker | Chemistry, 1997 |
| Roger Kornberg | Chemistry, 2006 |
| Edvard Moser | Physiology or Medicine, 2014 |
| May-Britt Moser | Physiology or Medicine, 2014 |
| Jerome Friedman | Physics, 1990 |
| Ben Feringa | Chemistry, 2016 |
| Roger Penrose | Physics, 2020 |
| Morten Meldal | Chemistry, 2022 |
| Paul Nurse | Physiology or Medicine, 2001 |
| Didier Queloz | Physics, 2019 |
| Johann Deisenhofer | Chemistry, 1988 |
| Kurt Wüthrich | Chemistry, 2002 |
| Richard J. Roberts | Physiology or Medicine, 1993 |
| Reinhard Genzel | Physics, 2020 |
| Klaus von Klitzing | Physics, 1985 |
| Françoise Barré-Sinoussi | Physiology or Medicine, 2008 |
| Hartmut Michel | Chemistry, 1988 |
| Michael Levitt | Chemistry, 2013 |
| Aaron Ciechanover | Chemistry, 2004 |
| Christiane Nüsslein-Volhard | Physiology or Medicine, 1995 |
| Jean-Marie Lehn | Chemistry, 1987 |
| Torsten Wiesel | Physiology or Medicine, 1981 |
| Phillip A. Sharp | Physiology or Medicine, 1993 |
| Erwin Neher | Physiology or Medicine, 1991 |
| Guido Imbens | Economic Sciences, 2021 |
| John O’Keefe | Physiology or Medicine, 2014 |
| Drew Weissman | Physiology or Medicine, 2023 |
| Konstantin Novoselov | Physics, 2010 |
| Roderick MacKinnon | Chemistry, 2003 |
| Eric S. Maskin | Economic Sciences, 2007 |
| David W. C. MacMillan | Chemistry, 2021 |
| Charles M. Rice | Physiology or Medicine, 2020 |
| Benjamin List | Chemistry, 2021 |
| Arieh Warshel | Chemistry, 2013 |
| Carolyn R. Bertozzi | Chemistry, 2022 |
| Michael Woodford | Economic Sciences, 2026 |
| Takaaki Kajita | Physics, 2015 |
| Peter Agre | Chemistry, 2003 |
| Donna Strickland | Physics, 2018 |
| Philippe Aghion | Economics, 2025 |
| Mario Capecchi | Physiology or Medicine, 2007 |
| Steven Chu | Physics, 1997 |
| John Polanyi | Chemistry, 1986 |
| Georg Nagel | Physiology or Medicine, 2026 |
| Michel Mayor | Physics, 2019 |
| Serge Haroche | Physics, 2012 |
| Jennifer A. Doudna | Chemistry, 2020 |
| Thomas Südhof | Physiology or Medicine, 2013 |
| Richard Henderson | Chemistry, 2017 |
| Jean-Pierre Sauvage | Chemistry, 2016 |
| Francis Halzen | Physics, 2026 |
| Anton Zeilinger | Physics, 2022 |
| Anne L'Huillier | Physics, 2023 |
| Oliver Hart | Economic Sciences, 2016 |
| Giorgio Parisi | Physics, 2021 |
| Carlo Rubbia | Physics, 1984 |
| Stefan Hell | Chemistry, 2014 |
| Peter Ratcliffe | Physiology or Medicine, 2019 |
| Emmanuelle Charpentier | Chemistry, 2020 |
| André Geim | Physics, 2010 |
| Tim Hunt | Physiology or Medicine, 2001 |
| Ferenc Krausz | Physics, 2023 |
| Michael Houghton | Physiology or Medicine, 2020 |
| Robert Huber | Chemistry, 1988 |
| W. E. Moerner | Chemistry, 2014 |
| Michael Rosbash | Physiology or Medicine, 2017 |
| Martin Chalfie | Chemistry, 2008 |
| Susumu Kitagawa | Chemistry, 2025 |
| Yuan Tseh Lee | Chemistry, 1986 |
About the Initiative for Science in Europe (ISE)#
The Initiative for Science in Europe (ISE) brings together European scientific organisations to represent the interests of the scientific community and contribute to European research policy.
Press contact#
Helge Pfeiffer Executive Director – Initiative for Science in Europe (ISE)helge.pfeiffer@initiative-se.eu

https://initiative-se.eu
Download the press statement
.Download the open letter
.
